Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020

被引:673
作者
不详
机构
关键词
GLARGINE; 100; U/ML; PEPTIDE-1 RECEPTOR AGONIST; TO-TARGET TRIAL; ORAL ANTIHYPERGLYCEMIC DRUGS; INITIAL COMBINATION THERAPY; PROTAMINE HAGEDORN INSULIN; GLUCOSE-LOWERING DRUGS; REGULAR HUMAN INSULIN; BASAL-BOLUS REGIMEN; ADD-ON THERAPY;
D O I
10.2337/dc20-S009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc20-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc20-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
引用
收藏
页码:S98 / S110
页数:13
相关论文
共 87 条
  • [1] A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients
    Abd El Aziz, Mirna S.
    Kahle, Melanie
    Meier, Juris J.
    Nauck, Michael A.
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (02) : 216 - 227
  • [2] Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial
    Abdul-Ghani, M. A.
    Puckett, C.
    Triplitt, C.
    Maggs, D.
    Adams, J.
    Cersosimo, E.
    DeFronzo, R. A.
    [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (03) : 268 - 275
  • [3] Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study
    Akturk, Halis Kaan
    Snell-Bergeon, Janet K.
    Rewers, Amanda
    Klaff, Leslie J.
    Bode, Bruce W.
    Peters, Anne L.
    Bailey, Timothy S.
    Garg, Satish K.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (10) : 639 - 647
  • [4] [Anonymous], MICR 20 INTR RED BOO
  • [5] [Anonymous], AM DIABETES ASS JDRF
  • [6] [Anonymous], NADAC NAT AV DRUG AC
  • [7] [Anonymous], 2015, FDA Drug Safety Communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood
  • [8] [Anonymous], 2018, DIABETOLOGIA, DOI DOI 10.1007/s00125-018-4729-5
  • [9] Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study
    Aroda, Vanita R.
    Edelstein, Sharon L.
    Goldberg, Ronald B.
    Knowler, William C.
    Marcovina, Santica M.
    Orchard, Trevor J.
    Bray, George A.
    Schade, David S.
    Temprosa, Marinella G.
    White, Neil H.
    Crandall, Jill P.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (04) : 1754 - 1761
  • [10] SAFE AND SIMPLE EMERGENCY DEPARTMENT DISCHARGE THERAPY FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS AND SEVERE HYPERGLYCEMIA
    Babu, Ambika
    Mehta, Avinder
    Guerrero, Pilar
    Chen, Zhen
    Meyer, Peter M.
    Koh, Chung Kay
    Roberts, Rebecca
    Schaider, Jeffrey
    Fogelfeld, Leon
    [J]. ENDOCRINE PRACTICE, 2009, 15 (07) : 696 - 704